ISTH 2022 Congress
Hemostatic Systems in Cancer, Inflammation and Immunity » Platelets and Cancer
Theme Navigation
- ISTH 2022 Congress
- Hemostatic Systems in Cancer, Inflammation and Immunity
- Platelets and Cancer
- Hemostatic Systems in Cancer, Inflammation and Immunity
-
Abstract Number: VPB0759
Cancer-associated fibroblasts promote venous thrombosis through C-type lectin-like receptor 2/podoplanin in 3LL lung cancer mouse model
-
Abstract Number: PB0750
Changes to platelet quality and function in Waldenstrӧm Macroglobulinaemia
-
Abstract Number: PB0748
Diminished platelet CLEC-2 sensitivity in kaposiform hemangioendothelioma identified with novel CLEC-2 antagonists
-
Abstract Number: VPB0760
Heightened Procoagulation After Thromboprophylaxis Completion inOrthopaedic Surgery Patients with Metastatic Bone Disease: Outcome of A Pilot Study
-
Abstract Number: VPB0758
JAK2 V617F Confers Aspirin Resistance in Patients with Myeloproliferative Neoplasms
-
Abstract Number: OC 72.3
JAK2V617F mutation exacerbates the thrombo-inflammatory response to Cerebral Venous Sinus Thrombosis in mice
-
Abstract Number: PB0752
Platelet and immune cell cloaking of circulating tumour cells [CTCs] in breast and ovarian cancer
-
Abstract Number: PB0753
Platelet count as a novel diagnostic marker for early lung cancer diagnosis: an epidemiological study
-
Abstract Number: OC 66.2
Platelet-mediated potentiation of the lung pre-metastatic niche in breast cancer
-
Abstract Number: PB0751
Platelets are integral components of the tumor microenvironment whose regulatory actions vary with the tumor type
-
Abstract Number: PO0043
Post-thrombotic hypercoagulation syndrome in patients with hemoblastoses
-
Abstract Number: PB0756
Proteomic and functional profile of platelet-derived extracellular vesicles released under physiological and tumour-associated conditions
-
Abstract Number: VPB0761
Severe hemorrhage complicated with acute multiple cerebral infarction in a patient with thrombocytopenia caused by chemotherapy
-
Abstract Number: PB0749
Significance of platelet count at diagnosis and its association with survival in Myelodysplastic Syndrome patients; an experience from Pakistan
-
Abstract Number: PB0755
Synthetic Bcr-Abl tyrosine kinase inhibitors; their profile towards antiplatelet activity and cancer cell functionality
-
Abstract Number: OC 66.3
The Lung Pro-thrombotic Niche Drives Cancer-Associated Thromboembolism via Exosomal ITGB2
-
Abstract Number: PB0754
Treatment of hepatocellular carcinoma with autologous platelets encapsulating sorafenib or lenvatinib: a novel therapy exploiting tumor-platelet interactions
-
Abstract Number: VPB0757
TREGs-induced Immune Thrombotic Thrombocytopenia in Polycythemia Vera